CDL now offers three solutions for cardiovascular imaging needs
News | Cardiac Imaging
CDL Nuclear Technologies Launches New Mobile Cardiac PET/CT Trailer

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Home April 23, 2024
Home
Using two primary markers‑— coronary calcium and heart chamber size — A routine chest scan without contrast shows promise for disease detection
News | Artificial Intelligence
Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial ...

Home April 23, 2024
Home
Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus valve
News | Cardiovascular Surgery
Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...

Home April 23, 2024
Home
A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure
News | Computed Tomography (CT)
Novel CT Exam Reduces Need for Invasive Artery Treatment

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection.
News | FDA
RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE Technologies ...

Home April 22, 2024
Home
Second major trial for atrial shunt therapy demonstrates importance of patient selection
News | Cardiovascular Clinical Studies
Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
New evidence published in Heart Rhythm underpins why the blanking period should be shortened
News | Atrial Fibrillation
Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
AI-enriched platform transforms disparate data into actionable insights for care providers and partners, boosts patient engagement and access to care for improved outcomes at lower cost
News | Artificial Intelligence
Karoo Health Launches Proprietary Technology Platform Kohere.ai to Supercharge Its Cardiac Value-based Care Model

April 18, 2024 — Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published ...

Home April 18, 2024
Home
AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms
News | FDA
AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

Home April 18, 2024
Home
Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease
News | Stents
Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
Mike Black
News | Heart Valve Technology
CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
Complications during procedures only contributed to death in about 20% of cases
News | Heart Failure
Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
News | Vascular Closure Devices
Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home April 16, 2024
Home
Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
News | Cardiovascular Clinical Studies
CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called Extrinsic Outflow Graft Obstruction, (EOGO).
News | FDA
FDA Announces Recalls of Abbott/Thoratec Corp. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction

April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...

Home April 15, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now